A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 2001

Conditions
Mycobacterium Avium-intracellulare InfectionHIV Infections
Interventions
DRUG

Nelfinavir mesylate

DRUG

Nevirapine

DRUG

Azithromycin

Trial Locations (26)

10003

Beth Israel Med Ctr, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10021

St Vincent's Hosp / Mem Sloan-Kettering Cancer Ctr, New York

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

19104

Univ of Pennsylvania at Philadelphia, Philadelphia

20059

Howard Univ, Washington D.C.

29169

Julio Arroyo, West Columbia

30308

Emory Univ, Atlanta

35294

Univ of Alabama at Birmingham, Birmingham

44106

Case Western Reserve Univ, Cleveland

46202

Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis

60611

Northwestern Univ Med School, Chicago

60612

Cook County Hosp, Chicago

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

75390

Univ of Texas, Southwestern Med Ctr of Dallas, Dallas

98104

Univ of Washington, Seattle

331361013

Univ of Miami School of Medicine, Miami

432101228

Ohio State Univ Hosp Clinic, Columbus

452670405

Univ of Cincinnati, Cincinnati

462025250

Indiana Univ Hosp, Indianapolis

775550435

Univ of Texas Galveston, Galveston

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

921036325

Univ of California / San Diego Treatment Ctr, San Diego

943055107

Stanford Univ Med Ctr, Stanford

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000895 - A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection | Biotech Hunter | Biotech Hunter